Factors such as novel treatments to boost the leukemia market, raise leukemia incidence, and rising aging demographics are projected to accelerate demand growth. Growth in the market for leukemia therapy is also driven by the rise in leukemia therapy cases, which further creates a space for the introduction of the new therapy and rich, promising pipeline drugs
read more..